Evidence map›Paper›PMID 21385872›Full record

ArticleThe Journal of biological chemistry2011

Proteomic analysis of the Vibrio cholerae type II secretome reveals new proteins, including three related serine proteases.

Aleksandra E Sikora, Ryszard A Zielke, Daniel A Lawrence, Philip C Andrews, Maria Sandkvist

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 125 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Identification of Effectors: Precipitation of Supernatant Material.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  12. Review
  13. Mechanism of secretion of TcpF by theProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  14. Uncovering the Secretion Systems ofAntibiotics (Basel, Switzerland) · 2023
    Review
  15. Frontiers in medicine · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Aleksandra E SikoraDepartment of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan 48109, USA.
Ryszard A Zielke
Daniel A Lawrence
Philip C Andrews
Maria Sandkvist
University of Michigan–Ann Arbor · USMichigan Medicine · US

Funding

Vaccines and Therapies Against BotulismU54AI057153 · NIAID · UNIVERSITY OF CHICAGO · PI MISSIAKAS, DOMINIQUE M. · 2003 to 2013
$87.6M
tPA and LRP in StrokeP01HL054710 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI STRICKLAND, DUDLEY K. · 1996 to 2011
$17.3M
Unraveling the role of tPA in the neurovascular unitR01HL055374 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI David Antonetti, Daniel A Lawrence · 1995 to 2026
$8.6M
Thrombotic/Fibrinolytic Balance in Cardiac Transplant VasculopathyP01HL089407 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LAWRENCE, DANIEL A · 2008 to 2012
$7.9M
Targeting type II secretion, a common virulence pathwayR01AI081705 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SANDKVIST, MARIA B · 2009 to 2010
$760k
NHLBI NIH HHS HL089407NHLBI NIH HHS HL54710NHLBI NIH HHS HL55374NHLBI NIH HHS P01 HL054710NHLBI NIH HHS P01 HL089407NHLBI NIH HHS R01 HL055374NIAID NIH HHS 1-U54-AI-057153NIAID NIH HHS R01 AI081705NIAID NIH HHS R01AI081705NIAID NIH HHS U54 AI057153
6 · The paper itself

Abstract

The type II secretion (T2S) system is responsible for extracellular secretion of a broad range of proteins, including toxins and degradative enzymes that play important roles in the pathogenesis and life cycle of many gram-negative bacteria. In Vibrio cholerae, the etiological agent of cholera, the T2S machinery transports cholera toxin, which induces profuse watery diarrhea, a hallmark of this life-threatening disease. Besides cholera toxin, four other proteins have been shown to be transported by the T2S machinery, including hemagglutinin protease, chitinase, GbpA, and lipase. Here, for the first time, we have applied proteomic approaches, including isotope tagging for relative and absolute quantification coupled with multidimensional liquid chromatography and tandem mass spectrometry, to perform an unbiased and comprehensive analysis of proteins secreted by the T2S apparatus of the V. cholerae El Tor strain N16961 under standard laboratory growth conditions. This analysis identified 16 new putative T2S substrates, including sialidase, several proteins participating in chitin utilization, two aminopeptidases, TagA-related protein, cytolysin, RbmC, three hypothetical proteins encoded by VCA0583, VCA0738, and VC2298, and three serine proteases VesA, VesB, and VesC. Focusing on the initial characterization of VesA, VesB, and VesC, we have confirmed enzymatic activities and T2S-dependent transport for each of these proteases. In addition, analysis of single, double, and triple protease knock-out strains indicated that VesA is the primary protease responsible for processing the A subunit of cholera toxin during in vitro growth of the V. cholerae strain N16961.

Indexed as

AnimalsBacterial ProteinsChromatography, LiquidCloning, MolecularElectrophoresis, Polyacrylamide GelGene DeletionGenetic TechniquesMass SpectrometryMiceProtein Structure, TertiaryProteomeProteomicsSerine ProteasesTandem Mass SpectrometryVibrio choleraeBacterial ProteinsProteomeSerine Proteases

Identifiers

PMID21385872
PMCPMC3089498
OpenAlexW2050254269

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.